Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vodafone Group PLC Director's Dealing 2020

Feb 27, 2020

5275_dirs_2020-02-27_a7ac0be6-27f2-4323-a793-06385ce19807.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3937E

Vodafone Group Plc

27 February 2020

VODAFONE GROUP PLC

(the "Company")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Purchase of shares

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Thodey

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Vodafone Group Plc

b)

LEI

549300MSQV80HSATBG53

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of US$0.20 20/21 each in Vodafone Group Plc (ISIN: GB00BH4HKS39)

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
GBP 1.51 203,653

d)

Aggregated information:  volume, Price

Aggregated volume: 203,653 Ordinary shares

Aggregated price: GBP 307,516.03

e)

Date of the transaction

2020-02-25

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFLFESFVIDFII